Bookmark

Add to MyYahoo RSS

Acclarent News

News on Acclarent (Ticker: JNJ) continually updated from thousands of sources around the net.

Yesterday | Salt Lake Tribune

Smartphone apps to help patients take their meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Yesterday | Seeking Alpha

Johnson & Johnson A Clear Pick In A Turbulent Market

JNJ stock has gained 9% this year, outperforming the S&P, and showing the company's staying power in tricky times.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Monday | The Huffington Post

Amanda Peet: Every Child's Wishes And Dreams Matter

This post is part of the Global Moms Relay . Every time you share this post, Johnson & Johnson will donate $1 , up to $250,000, to the Global Moms Relay, to help improve the health and well-being of moms and kids worldwide in support of MAMA , Shot@Life , and Girl Up .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Monday | The Motley Fool

Warfarin's Loss is Johnson & Johnson's Gain

Warfarin has long been doctor's go-to medicine for guarding against blood clots in post-operative or cardiovascular disease patients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Monday | PR-inside.com

Russia baby products market: Johnson & Johnson continues to dominate during 2012

The company held a 19% value share, having a wide presence in all regions of Russia.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Apr 18, 2014

BioSpace

Johnson & Johnson Starts Construction On $300 Million China Plant

For J&J, the new facility is its biggest single investment in a plant and its largest production facility .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

PR-inside.com

Belgium digestive remedies market: Janssen-Cilag the dominant industry player during 2012

Janssen-Cilag was the undisputed leader in a fragmented competitive environment in the Belgium digestive remedies market in 2012.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Apr 17, 2014

Examiner.com

How your green business can encourage consumers to recycle

Nearly three-quarters of consumers consistently recycle in the home, but only about half do so in rooms beyond the kitchen.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Argus Increases Johnson & Johnson Price Target to $116.00

The firm currently has a "buy" rating on the stock. Argus' target price suggests a potential upside of 16.94% from the stock's previous close.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Apr 16, 2014

The Motley Fool

Is Johnson & Johnson's Dividend Unbeatable?

Major health-care stocks out of big pharma and medical devices offer great dividends, but few offer the strength and reliability of sector colossus Johnson & Johnson .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Contract Pharma Breaking News

Financial Report: Johnson & Johnson 1Q

Johnson & Johnson 1Q Revenues: $18.1 billion 1Q Earnings: $4.7 billion Comments: Worldwide pharmaceutical sales were $7.5 billion, up 11%, driven by STELARA, INVEGA, SUSTENNA/XEPLION, PREZISTA, and VELCADE, as well as new products OLYSIO/SOVRIAD, a combination treatment of chronic hepatitis C, and ZYTIGA for the treatment of prostate cancer.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

SFGate

Smartphone apps to help patients take their meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Investopedia

Earnings Outlook is the Key Factor - Ahead of Wall Street

The benign inflation reading and a soft Empire State manufacturing survey are the only notable economic reports today.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Apr 15, 2014

Investor's Business Daily

Major Averages Reverse Early Losses In Higher Volume

Tuesday was shaping up to be another ugly day for the stock market, but major averages recovered impressively and closed near highs on a busy day of headline flow.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

PR-inside.com

Taiwan baby products market: Johnson & Johnson and BA1 4bchen the...

These include Johnson & Johnson, BA1 4bchen, Sebamed, Chicco and Pigeon, which together accounted for 71% of total sales in 2012.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Johnson & Johnson (JNJ) Updates FY14 Earnings Guidance

Johnson & Johnson issued an update on its FY14 earnings guidance on Tuesday morning.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Coast Reporter

Johnson & Johnson's Q1 profit rises 8 pct on lower spending, surge in prescription drug sales

Johnson & Johnson says its first-quarter profit rose 8 per cent, because of restrained costs and a big jump in prescription drug sales.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Apr 14, 2014

BioSpace

Johnson & Johnson Innovation Center Joins Advance Drug Discovery Effort

The Scripps Research Institute has joined with Johnson & Johnson Innovation Center and other partners to launch a new drug discovery effort designed to translate early-stage biomedical research projects into new treatments.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Johnson & Johnson (JNJ) to Release Quarterly Earnings on Tuesday

Johnson & Johnson is scheduled to be announcing its Q114 earnings results on Tuesday, April 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Apr 11, 2014

Forbes.com

Forbes Earnings Preview: Johnson & Johnson

Johnson & Johnson reports its first-quarter earnings on Tuesday, April 15, 2014, and the consensus earnings per share estimate is $1.48 per share.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••